HEALTH NUCLEUS Trademark

Trademark Overview


On Tuesday, January 5, 2016, a trademark application was filed for HEALTH NUCLEUS with the United States Patent and Trademark Office. The USPTO has given the HEALTH NUCLEUS trademark a serial number of 86865972. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, May 2, 2019. This trademark is owned by HLI Nucleus Holdings, LLC. The HEALTH NUCLEUS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

scientific research services in the field of genomics and advanced clinical imaging to be used for personalized health; research and development in the field of genome sequencing and genome analysis; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment, and preparing related information reports therefor; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment through advanced clinical imaging, namely, ultrasound...

genetic testing of humans for medical diagnostic purposes; consulting services in the fields of diagnostic medical testing; DNA screening for medical purposes; genetic counseling; medical assistance consultancy provided by doctors and other specialized medical personnel; medical assistance consultancy provided by genomics and genetics experts; medical assistance services in the nature of genetic and medical information provided to medical professionals from remote locations via the internet and global computer networks through the use of archived genome sequence information, medical images, diagnostic test results, and a data storage and retrieval system; medical genetic testing consultations provided via phone, online chat or videoconferencing; medical diagnostic testing, monitoring and reporting services; medical imaging services; medical information; medical screening; medical testing for diagnostic purposes; medical testing of blood, saliva, stool; multi-disciplinary, integrative, ...
health nucleus

General Information


Serial Number86865972
Word MarkHEALTH NUCLEUS
Filing DateTuesday, January 5, 2016
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, May 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"HEALTH"
Description of MarkThe mark consists of the words "HEALTH NUCLEUS" in stylized font with a solid circle in the center of the "C".
Goods and Servicesscientific research services in the field of genomics and advanced clinical imaging to be used for personalized health; research and development in the field of genome sequencing and genome analysis; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment, and preparing related information reports therefor; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammaography, and echocardiogram services, and preparing related information reports therefor; providing online searchable databases in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping, molecular analytics, patient scientific and medical information, genealogical information, advanced clinical imaging, health risk assessment for scientific research purposes; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, all in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, and health risk assessment; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment, and genealogical information; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammaography, and echocardiogram services, and genealogical information; medical research; scientific investigations for medical purposes; medical and scientific research in the field of medical imaging; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research in the field of genome sequence analysis and genome sequence reporting for research purposes, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; research and development in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; scientific research for medical purposes in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; genetic testing of humans for scientific research purposes; all for scientific research purposes
Goods and Servicesgenetic testing of humans for medical diagnostic purposes; consulting services in the fields of diagnostic medical testing; DNA screening for medical purposes; genetic counseling; medical assistance consultancy provided by doctors and other specialized medical personnel; medical assistance consultancy provided by genomics and genetics experts; medical assistance services in the nature of genetic and medical information provided to medical professionals from remote locations via the internet and global computer networks through the use of archived genome sequence information, medical images, diagnostic test results, and a data storage and retrieval system; medical genetic testing consultations provided via phone, online chat or videoconferencing; medical diagnostic testing, monitoring and reporting services; medical imaging services; medical information; medical screening; medical testing for diagnostic purposes; medical testing of blood, saliva, stool; multi-disciplinary, integrative, genetic consultations for medical treatment purposes; providing a web site featuring genetic and medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing medical information; providing medical information, consultancy and advisory services; providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms, concerns, genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; providing medical testing and medical consultations to individuals and their physicians to help them make health, wellness and nutritional changes in their daily living to improve health; providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms based on genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; provision of health care and medical services by health care professionals via the internet or telecommunication networks; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; health assessment services, namely, providing assessment of risk of disease and providing health monitoring of individuals all through use of genome sequencing analysis and reporting, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; all for medical treatment and diagnostic purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2016
Primary Code042
First Use Anywhere DateMonday, August 31, 2015
First Use In Commerce DateMonday, October 12, 2015

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2016
Primary Code044
First Use Anywhere DateMonday, August 31, 2015
First Use In Commerce DateMonday, October 12, 2015

Trademark Owner History


Party NameHLI Nucleus Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, May 6, 2019ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, May 2, 2019ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, May 2, 2019EXPARTE APPEAL TERMINATED
Thursday, May 2, 2019EXPARTE APPEAL DISMISSED
Thursday, April 11, 2019NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Thursday, April 11, 2019EXAMINERS STATEMENT E-MAILED
Thursday, April 11, 2019EXAMINERS STATEMENT - COMPLETED
Monday, March 4, 2019ASSIGNED TO EXAMINER
Wednesday, February 13, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, June 12, 2018EX PARTE APPEAL-INSTITUTED
Tuesday, June 12, 2018EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, December 13, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 13, 2017FINAL REFUSAL E-MAILED
Wednesday, December 13, 2017FINAL REFUSAL WRITTEN
Tuesday, November 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 19, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 19, 2017NON-FINAL ACTION E-MAILED
Friday, May 19, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 9, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, May 9, 2017ASSIGNED TO LIE
Tuesday, November 1, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 1, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, November 1, 2016SUSPENSION LETTER WRITTEN
Wednesday, October 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2016NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2016NON-FINAL ACTION WRITTEN
Tuesday, April 12, 2016ASSIGNED TO EXAMINER
Thursday, January 14, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 8, 2016NEW APPLICATION ENTERED IN TRAM